EVOTEC AG O.N.

Premiumpartner

Firmenbeschreibung

Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Free float (75%),Triton GP HoldCo SARL (10%),Novo Holdings A/S (8%),Mubadala Investment Company (7%)
sharesOutstanding: 177553456.0000
ceo: Dr Christian Wojczewski
board: Paul Hitchin, Dr. Cord Dohrmann, Aurélie Dalbiez
supervisoryBoard: Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Camilla Macapili Languille, Dr. Duncan McHale, Wes Wheeler, Roland Sackers
countryID: 2
freeFloat: 62.1900
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: Deutschland
countryName: Deutschland

Kontakt

name: Volker Braun
phone: +49-40-56081-775
fax: +49-40-56081-222
email: InvestorRelations@evotec.com
irWebSite: https://www.evotec.com/en/investor-relations

Adresse

street: Essener Bogen 7
city: D-22419 Hamburg
phone: +49-40-56081-0
fax: +49-40-56081-222
webSite: www.evotec.com
email: info@evotec.com

Finanzen (kurz)

year: 2022 cash: 415.1600
balanceSheetTotal: 2257.2500 liabilities: 1070.0600
totalShareholdersEquity: 1187.1800 sales: 751.4500
investment: 8.3400 incomeBeforeTaxes: -153.9600
netIncome: -175.6600 employees: 4952
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 510.9090
balanceSheetTotal: 2252.4680 liabilities: 1132.5600
totalShareholdersEquity: 1119.9080 sales: 781.4260
investment: 9.2630 incomeBeforeTaxes: -80.5930
netIncome: -83.9130 employees: 5061
currencyID: 1 units: 1000000
currency: EUR
year: 2024 cash: 306.3870
balanceSheetTotal: 1912.5020 liabilities: 959.9770
totalShareholdersEquity: 952.5250 sales: 796.9670
investment: 2.4350 incomeBeforeTaxes: -193.9770
netIncome: -196.0780 employees: 4827
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2022
cash: 415.1600
balanceSheetTotal: 2257.2500
liabilities: 1070.0600
totalShareholdersEquity: 1187.1800
sales: 751.4500
investment: 8.3400
incomeBeforeTaxes: -153.9600
netIncome: -175.6600
employees: 4952
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 510.9090
balanceSheetTotal: 2252.4680
liabilities: 1132.5600
totalShareholdersEquity: 1119.9080
sales: 781.4260
investment: 9.2630
incomeBeforeTaxes: -80.5930
netIncome: -83.9130
employees: 5061
currencyID: 1
units: 1000000
currency: EUR
year: 2024
cash: 306.3870
balanceSheetTotal: 1912.5020
liabilities: 959.9770
totalShareholdersEquity: 952.5250
sales: 796.9670
investment: 2.4350
incomeBeforeTaxes: -193.9770
netIncome: -196.0780
employees: 4827
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2023 units: 1000000
balanceSheetTotal: 2252.4680 cash: 510.9090
currentAssets: 903.1620 fixedAssets: 1349.3060
liabilities: 464.5730 nonCurrentLiabilities: 667.9870
totalLiabilitiesEquity: 2252.4680 provisions: 79.3650
totalShareholdersEquity: 1119.9080 employees: 5061
property: 806.5630 intangibleAssets: 15.4530
longTermInvestments: 142.0940 inventories: 30.8900
accountsReceivable: 98.3960 accountsPayable: 134.3190
liabilitiesTotal: 1132.5600 longTermDebt: 477.1120
shortTermDebt: 149.0960 minorityInterests: 0.0000
sales: 781.4260 netIncome: -83.9130
operatingResult: -47.5070 incomeInterest: -2.4760
investments: 68.5290 incomeTaxes: 3.3200
costGoodsSold: 606.3750 grossProfit: 175.0510
minorityInterestsProfit: 0.0000 revenuePerEmployee: 154401.5017
cashFlow: 36.4390 cashFlowInvesting: -13.2910
cashFlowFinancing: 71.9630 accountingStandard: IFRS
equityRatio: 49.7192 debtEquityRatio: 101.1297
liquidityI: 109.9739 liquidityII: 131.1538
netMargin: -10.7384 grossMargin: 22.4015
cashFlowMargin: 4.6631 ebitMargin: -6.0795
ebitdaMargin: 0.0000 preTaxROE: -7.1964
preTaxROA: -3.5780 roe: -7.4928
roa: -3.7254 netIncomeGrowth: -52.2299
revenuesGrowth: 3.9891 taxExpenseRate: -4.1195
equityTurnover: 0.6978 epsBasic: -0.4700
epsBasicGrowth: -52.5253 incomeBeforeTaxes: -80.5930
priceCashFlowRatio: 103.3175 bookValuePerShare: 6.3301
marketCap: 3764786588.6400 earningsYield: -2.2086
cashFlowPerShare: 0.2060 netAssetsPerShare: 6.3301
priceBookValueRatio: 3.3617 netEarningsPerShare: -0.4743
currency: EUR
year: 2024 units: 1000000
balanceSheetTotal: 1912.5020 cash: 306.3870
currentAssets: 681.9640 fixedAssets: 1230.5380
liabilities: 344.5850 nonCurrentLiabilities: 615.3920
totalLiabilitiesEquity: 1912.5020 provisions: 81.8040
totalShareholdersEquity: 952.5250 employees: 4827
property: 823.9370 intangibleAssets: 26.4410
longTermInvestments: 2.1380 inventories: 90.4130
accountsReceivable: 116.3190 accountsPayable: 85.7920
liabilitiesTotal: 959.9770 longTermDebt: 392.7430
shortTermDebt: 50.7950 minorityInterests: 0.0000
sales: 796.9670 netIncome: -196.0780
operatingResult: -142.5220 incomeInterest: -9.2640
investments: 50.8570 incomeTaxes: 2.1020
costGoodsSold: 682.0860 grossProfit: 114.8810
minorityInterestsProfit: 0.0000 revenuePerEmployee: 165106.0700
cashFlow: 18.2200 cashFlowInvesting: -71.1870
cashFlowFinancing: -161.4210 accountingStandard: IFRS
equityRatio: 49.8052 debtEquityRatio: 100.7823
liquidityI: 88.9148 liquidityII: 122.6710
netMargin: -24.6030 grossMargin: 14.4148
cashFlowMargin: 2.2862 ebitMargin: -17.8830
ebitdaMargin: 0.0000 preTaxROE: -20.3645
preTaxROA: -10.1426 roe: -20.5851
roa: -10.2524 netIncomeGrowth: 133.6682
revenuesGrowth: 1.9888 taxExpenseRate: -1.0836
equityTurnover: 0.8367 epsBasic: -1.1100
epsBasicGrowth: 136.1702 incomeBeforeTaxes: -193.9770
priceCashFlowRatio: 79.8601 bookValuePerShare: 5.3647
marketCap: 1455050571.9200 earningsYield: -13.5448
cashFlowPerShare: 0.1026 netAssetsPerShare: 5.3647
priceBookValueRatio: 1.5276 netEarningsPerShare: -1.1043
currency: EUR
year: 2025 priceCashFlowRatio: 62.3289
bookValuePerShare: 5.3647 marketCap: 1135631904.5760
earningsYield: -17.3546 pegRatio: -0.0423
cashFlowPerShare: 0.1026 netAssetsPerShare: 5.3647
priceBookValueRatio: 1.1922 netEarningsPerShare: -1.1043
currency: EUR

Finanzen (ausführlich)

year: 2023
units: 1000000
balanceSheetTotal: 2252.4680
cash: 510.9090
currentAssets: 903.1620
fixedAssets: 1349.3060
liabilities: 464.5730
nonCurrentLiabilities: 667.9870
totalLiabilitiesEquity: 2252.4680
provisions: 79.3650
totalShareholdersEquity: 1119.9080
employees: 5061
property: 806.5630
intangibleAssets: 15.4530
longTermInvestments: 142.0940
inventories: 30.8900
accountsReceivable: 98.3960
accountsPayable: 134.3190
liabilitiesTotal: 1132.5600
longTermDebt: 477.1120
shortTermDebt: 149.0960
minorityInterests: 0.0000
sales: 781.4260
netIncome: -83.9130
operatingResult: -47.5070
incomeInterest: -2.4760
investments: 68.5290
incomeTaxes: 3.3200
costGoodsSold: 606.3750
grossProfit: 175.0510
minorityInterestsProfit: 0.0000
revenuePerEmployee: 154401.5017
cashFlow: 36.4390
cashFlowInvesting: -13.2910
cashFlowFinancing: 71.9630
accountingStandard: IFRS
equityRatio: 49.7192
debtEquityRatio: 101.1297
liquidityI: 109.9739
liquidityII: 131.1538
netMargin: -10.7384
grossMargin: 22.4015
cashFlowMargin: 4.6631
ebitMargin: -6.0795
ebitdaMargin: 0.0000
preTaxROE: -7.1964
preTaxROA: -3.5780
roe: -7.4928
roa: -3.7254
netIncomeGrowth: -52.2299
revenuesGrowth: 3.9891
taxExpenseRate: -4.1195
equityTurnover: 0.6978
epsBasic: -0.4700
epsBasicGrowth: -52.5253
incomeBeforeTaxes: -80.5930
priceCashFlowRatio: 103.3175
bookValuePerShare: 6.3301
marketCap: 3764786588.6400
earningsYield: -2.2086
cashFlowPerShare: 0.2060
netAssetsPerShare: 6.3301
priceBookValueRatio: 3.3617
netEarningsPerShare: -0.4743
currency: EUR
year: 2024
units: 1000000
balanceSheetTotal: 1912.5020
cash: 306.3870
currentAssets: 681.9640
fixedAssets: 1230.5380
liabilities: 344.5850
nonCurrentLiabilities: 615.3920
totalLiabilitiesEquity: 1912.5020
provisions: 81.8040
totalShareholdersEquity: 952.5250
employees: 4827
property: 823.9370
intangibleAssets: 26.4410
longTermInvestments: 2.1380
inventories: 90.4130
accountsReceivable: 116.3190
accountsPayable: 85.7920
liabilitiesTotal: 959.9770
longTermDebt: 392.7430
shortTermDebt: 50.7950
minorityInterests: 0.0000
sales: 796.9670
netIncome: -196.0780
operatingResult: -142.5220
incomeInterest: -9.2640
investments: 50.8570
incomeTaxes: 2.1020
costGoodsSold: 682.0860
grossProfit: 114.8810
minorityInterestsProfit: 0.0000
revenuePerEmployee: 165106.0700
cashFlow: 18.2200
cashFlowInvesting: -71.1870
cashFlowFinancing: -161.4210
accountingStandard: IFRS
equityRatio: 49.8052
debtEquityRatio: 100.7823
liquidityI: 88.9148
liquidityII: 122.6710
netMargin: -24.6030
grossMargin: 14.4148
cashFlowMargin: 2.2862
ebitMargin: -17.8830
ebitdaMargin: 0.0000
preTaxROE: -20.3645
preTaxROA: -10.1426
roe: -20.5851
roa: -10.2524
netIncomeGrowth: 133.6682
revenuesGrowth: 1.9888
taxExpenseRate: -1.0836
equityTurnover: 0.8367
epsBasic: -1.1100
epsBasicGrowth: 136.1702
incomeBeforeTaxes: -193.9770
priceCashFlowRatio: 79.8601
bookValuePerShare: 5.3647
marketCap: 1455050571.9200
earningsYield: -13.5448
cashFlowPerShare: 0.1026
netAssetsPerShare: 5.3647
priceBookValueRatio: 1.5276
netEarningsPerShare: -1.1043
currency: EUR
year: 2025
priceCashFlowRatio: 62.3289
bookValuePerShare: 5.3647
marketCap: 1135631904.5760
earningsYield: -17.3546
pegRatio: -0.0423
cashFlowPerShare: 0.1026
netAssetsPerShare: 5.3647
priceBookValueRatio: 1.1922
netEarningsPerShare: -1.1043
currency: EUR